tiprankstipranks
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
US Market
ALDX
Aldeyra Therapeutics
RESEARCH TOOLSreports
Want to see ALDX full AI Analyst Report?

Aldeyra Therapeutics (ALDX) Income Statement

1,734 Followers

Aldeyra Therapeutics Income Statement

Last quarter (Q4 2025), Aldeyra Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Aldeyra Therapeutics's net income was $-6.46M. See Aldeyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -251.99K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 35.01M$ 60.12M$ 42.79M$ 62.68M$ 56.22M
Depreciation and Amortization
$ 251.99K$ 249.62K$ 262.78K$ 258.71K$ 264.18K
EBITDA
$ -31.69M$ -53.68M$ -35.21M$ -60.07M$ -55.77M
Operating Income
$ -35.27M$ -60.12M$ -42.79M$ -62.68M$ -56.22M
Other Income/Expenses
$ 1.42M$ 4.27M$ 5.25M$ 655.35K$ -1.56M
Pretax Income
$ -33.85M$ -55.85M$ -37.54M$ -62.02M$ -57.78M
Net Income
$ -33.85M$ -55.85M$ -37.54M$ -62.02M$ -57.78M
Per Share Metrics
Basic EPS
$ -0.56$ -0.94$ -0.64$ -1.06$ -1.07
Diluted EPS
$ -0.56$ -0.94$ -0.64$ -1.06$ -1.07
Weighted Average Shares Outstanding
 60.06M 59.48M 58.94M 58.41M 54.04M
Weighted Average Shares Outstanding (Diluted)
 60.06M 59.48M 58.94M 58.41M 54.04M
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History